{"id":"W4317433563","doi":"10.2217/fon-2022-0919","title":"A real-world study of second or later-line osimertinib in patients with EGFR T790M-positive NSCLC: the final ASTRIS data","year":2023,"lang":"en","type":"article","venue":"Future Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; William Osler Health System; BC Cancer Agency; University of Toronto","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; T790M; Oncology; Internal medicine; Second line; Real world data; First line; Epidermal growth factor receptor; Gefitinib; Cancer; Erlotinib; Data science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001382833,0.0001241442,0.0003291462,0.0001412811,0.00006132219,0.000005046601,0.000157222,0.00006098597,0.0002983654],"category_scores_gemma":[0.00002264454,0.00006327566,0.00001884191,0.0006311272,0.00005118548,0.000060125,0.0001072465,0.0001893824,0.00001740624],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001508499,"about_ca_system_score_gemma":0.0003662703,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004560123,"about_ca_topic_score_gemma":0.02034601,"domain_scores_codex":[0.9989902,0.00009968861,0.0002625297,0.0002820297,0.0001688246,0.0001966775],"domain_scores_gemma":[0.9990974,0.0001605082,0.0001345224,0.0004616645,0.00009494154,0.00005093638],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008439122,0.006743349,0.9031752,0.00006646458,0.001218243,0.0004987099,0.01412983,0.00002783897,0.00003117073,0.00004478573,0.02122887,0.04439642],"study_design_scores_gemma":[0.01345269,0.007233561,0.9583204,0.0000543663,0.0003934231,0.0000040952,0.002644375,0.00002419645,0.00002421946,0.000006318886,0.01777402,0.00006838471],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920695,0.00002341539,0.000001722472,0.002158711,0.0002296246,0.00127204,0.0003509463,0.00002690315,0.003867175],"genre_scores_gemma":[0.995173,0.00001393663,0.0001498146,0.0002725654,0.0002283497,0.00008884983,0.00100106,0.00001824368,0.003054163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05514516,"threshold_uncertainty_score":0.9975301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0400914084856207,"score_gpt":0.3892553444016239,"score_spread":0.3491639359160032,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}